12-101697908-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020244.3(CHPT1):c.47C>A(p.Ala16Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000216 in 1,385,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020244.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHPT1 | NM_020244.3 | c.47C>A | p.Ala16Glu | missense_variant | 1/9 | ENST00000229266.8 | |
CHPT1 | XM_011538574.2 | c.47C>A | p.Ala16Glu | missense_variant | 1/8 | ||
CHPT1 | XR_001748818.2 | n.269C>A | non_coding_transcript_exon_variant | 1/8 | |||
CHPT1 | XR_245946.3 | n.269C>A | non_coding_transcript_exon_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHPT1 | ENST00000229266.8 | c.47C>A | p.Ala16Glu | missense_variant | 1/9 | 1 | NM_020244.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150736Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000162 AC: 2AN: 1235016Hom.: 0 Cov.: 30 AF XY: 0.00000165 AC XY: 1AN XY: 605530
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150736Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73572
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.47C>A (p.A16E) alteration is located in exon 1 (coding exon 1) of the CHPT1 gene. This alteration results from a C to A substitution at nucleotide position 47, causing the alanine (A) at amino acid position 16 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at